I agree @Stonks, fair value of $2 is probably too conservative of an estimate. However, the view of myself and my institutional colleague is that conservative is always better than aggressive when it comes to valuation. Whilst the company will clearly perform will in excess of our forecasts, by taking a conservative approach we ensure that the risk of any unforeseen events are accounted for in the price target. As such, we have chosen a fair value price of $2 as opposed to one closer to $10 (which is closer to peer valuations during their own growth stages). Call me a bear or a downramper for suggesting such a low price target, but I feel this is the safe way to play it! Do you agree?
- Forums
- ASX - By Stock
- EYE Summary (August 2024): Incredibly Undervalued
I agree @Stonks, fair value of $2 is probably too conservative...
-
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $42.37M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.5¢ | $44.75K | 237.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 51300 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 26719 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 51300 | 0.185 |
10 | 269640 | 0.180 |
7 | 163500 | 0.175 |
7 | 89000 | 0.170 |
4 | 196060 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 26719 | 1 |
0.195 | 69100 | 3 |
0.200 | 109923 | 3 |
0.205 | 15050 | 1 |
0.210 | 40000 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online